Cryptotanshinone inhibits LPS-induced proinflammatory mediators via TLR4 and TAK1 signaling pathway

International Immunopharmacology

Volumn 11, Issue 11, 2011, Pages 1871-1876

  Li, Xin ^a   Lian, Li Hua ^a   Bai, Ting ^a   Wu, Yan Ling ^a   Wan, Ying ^a   Xie, Wen Xue ^a   Jin, Xuejun ^a   Nan, Ji Xing ^a  

^a YANBIAN UNIVERSITY   (China)

Author keywords

CD14; Cryptotanshinone; TAK1; TLR4

Indexed keywords

CD14 ANTIGEN; CRYPTOTANSHINONE; CYCLOOXYGENASE 2; GALACTOSAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SILYMARIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; IN VITRO STUDY; LETHALITY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD14; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MAP KINASE KINASE KINASES; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHENANTHRENES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 5;

EID: 80055014040     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.07.018     Document Type: Article

References (37)

1. B. Beutler, and E.T. Rietschel Innate immune sensing and its roots: the story of endotoxin Immunology 3 2003 169 176 (Pubitemid 37328694)
2. T. Yoon, M.S. Cheon, A.Y. Lee, Y. Lee do, B.C. Moon, and J.M. Chun Anti-inflammatory activity of methylene chloride fraction from Glehnia littoralis extract via suppression of NF-kappaB and mitogen-activated protein kinase activity J Pharmacol Sci 112 2010 46 55
3. S.H. Lee, E. Soyoola, P. Chanmugam, S. Hart, W. Sun, and H. Zhong Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide J Biol Chem 267 1992 25934 25938 (Pubitemid 23013998)
4. S.F. Kim, D.A. Huri, and S.H. Snyder Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2 Science 310 2005 1966 1970 (Pubitemid 43005992)
5. K. Subbaramaiah, and A.J. Dannenberg Cyclooxygenase 2: a molecular target for cancer prevention and treatment Trends Pharmacol Sci 24 2003 96 102 (Pubitemid 36135884)
6. Q. Jiang, S. Akashi, K. Miyake, and H.R. Petty Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B J Immunol 165 2000 3541 3544 (Pubitemid 32057253)
7. S. Akira, and K. Takeda Toll-like receptor signalling Nat Rev Immunol 4 2004 499 511 (Pubitemid 38931765)
8. A. Yagi, K. Fujimoto, K. Tanonaka, K. Hirai, and S. Takeo Possible active components of tan-shen (Salvia miltiorrhiza) for protection of the myocardium against ischemia-induced derangements Planta Med 55 1989 51 54 (Pubitemid 19058361)
9. S.Y. Kim, T.C. Moon, H.W. Chang, K.H. Son, S.S. Kang, and H.P. Kim Effects of tanshinone I isolated from Salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responses Phytother Res 16 2002 616 620 (Pubitemid 35334180)
10. I.J. Park, M.J. Kim, O.J. Park, M.G. Park, W. Choe, and I. Kang Cryptotanshinone sensitizes DU145 prostate cancer cells to Fas(APO1/CD95)- mediated apoptosis through Bcl-2 and MAPK regulation Cancer Lett 298 2010 88 98
11. W.Y. Lee, K.W. Liu, and J.H. Yeung Reactive oxygen species-mediated kinase activation by dihydrotanshinone in tanshinones-induced apoptosis in HepG2 cells Cancer Lett 285 2009 46 57
12. D.Z. Jin, D.Z. Yin, L.L. Yin, X.Q. Ji, and X.Z. Zhu Cryptotanshinone inhibits cyclooxygenase-2 enzyme activity but not its expression Eur J Pharmacol 549 2006 166 172
13. S. Tang, X.Y. Shen, H.Q. Huang, S.W. Xu, Y. Yu, and C.H. Zhou Cryptotanshinone suppressed inflammatory cytokines secretion in RAW264.7 macrophages through inhibition of the NF-kappaB and MAPK Signaling Pathways Inflammation 34 2011 111 118
14. B.A. Weissman, and S.S. Gross Measurement of NO and NO synthase Curr Protoc Neurosci Chapter 7 2001 13:Unit7
15. W.M. Moore, R.K. Webber, G.M. Jerome, F.S. Tjoeng, T.P. Misko, and M.G. Currie L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase J Med Chem 37 1994 3886 3888 (Pubitemid 24379677)
16. S.Y. Kim, T.C. Moon, H.W. Chang, K.H. Son, S.S. Kang, and H.P. Kim Effects of tanshinone I isolated from Salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responses Phytother Res 16 2002 616 620 (Pubitemid 35334180)
17. B.Y. Kang, S.W. Chung, S.H. Kim, S.Y. Ryu, and T.S. Kim Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorrhiza Immunopharmacology 49 2000 355 361
18. S.J. Jeon, K.H. Son, Y.S. Kim, Y.H. Choi, and H.P. Kim Inhibition of prostaglandin and nitric oxide production in lipopolysaccharide-treated RAW 264.7 cells by tanshinones from the roots of Salvia miltiorrhiza bunge Arch Pharm Res 31 2008 758 763
19. S.I. Jang, S.I. Jeong, K.J. Kim, H.J. Kim, H.H. Yu, and R. Park Tanshinone. IIA. from Salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF-alpha, IL-1beta and IL-6 in activated RAW 264.7 cells Planta Med 69 11 2003 Nov 1057 1059 (Pubitemid 38064700)
20. H.S. Choi, D.I. Cho, H.K. Choi, S.Y. Im, S.Y. Ryu, and K.M. Kim Molecular mechanisms of inhibitory activities of tanshinones on lipopolysaccharide- induced nitric oxide generation in RAW 264.7 cells Arch Pharm Res 27 2004 1233 1237
21. H. Nakano, M. Shindo, S. Sakon, S. Nishinaka, M. Mihara, and H. Yagita Differential regulation of IκB kinase alpha and beta by two upstream kinases NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1 Proc Natl Acad Sci USA 95 1998 3537 3542
22. O.W. Griffith, and D.J. Stuehr Nitric oxide synthases: properties and catalytic mechanism Annu Rev Physiol 57 1995 707
23. A. Pautz, J. Art, S. Hahn, S. Nowag, C. Voss, and H. Kleinert Regulation of the expression of inducible nitric oxide synthase Nitric Oxide 23 2010 75 93
24. V. Cattell, and A. Jansen Inducible nitric oxide synthase in inflammation Mol Med 6 2000 347 373
25. R. Zamora, Y. Vodovotz, and T.R. Billiar Inducible nitric oxide synthase and inflammatory diseases Mol Med 6 2000 347 373
26. J.D. Macmicking, Q.W. Xie, and C. Nathan Nitric oxide and macrophage function Annu Rev Immunol 15 1997 323 350 (Pubitemid 27169284)
27. A. Iezzi, C. Ferri, A. Mezzetti, and F. Cipollone COX-2: friend or foe? Curr Pharm Des 13 2007 1715 1721 (Pubitemid 46979725)
28. J.R. Vane, Y.S. Bakhle, and R.M. Botting Cyclooxygenases 1 and 2 Annu Rev Pharmacol Toxicol 38 1998 97 120 (Pubitemid 28231490)
29. D. Wu, M. Mark, K. Claycombe, K.E. Paulsonand, and S.N. Meydani Ceramide-induced and age-associated increase in macrophage COX-2 expression is mediated through up-regulation of NF-kappa B activity J Biol Chem 278 2003 10983 10992 (Pubitemid 36792646)
30. H.J. An, I.T. Kim, H.J. Park, H.M. Kim, J.H. Choi, and K.T. Lee Tormentic acid, a triterpenoid saponin, isolated from Rosa rugosa, inhibited LPS-induced iNOS, COX-2, and TNF-α expression through inactivation of the nuclear factor-κb pathway in RAW 264.7 macrophages Int Immunopharmacol 11 2011 504 510
31. T.K. Means, E. Lien, A. Yoshimura, S. Wang, D.T. Golenbock, and M.J. Fenton The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors J Immunol 163 1999 6748 6755
32. S.T. Qureshi, L. Lariviere, G. Leveque, S. Clermont, K.J. Moore, and P. Gros Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4) J Exp Med 189 1999 615 625 (Pubitemid 29193362)
33. H. Frobøse, S.G. Rønn, P.E. Heding, H. Mendoza, P. Cohen, and T. Mandrup-Poulsen Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex Mol Endocrinol 20 2006 1587 1596 (Pubitemid 43967566)
34. S.H. Rhee, and D. Hwang Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase J Biol Chem 275 2000 34035 34040
35. Y.C. Lu, W.C. Yeh, and P.S. Ohashi LPS/TLR4 signal transduction pathway Cytokine 42 2008 145 151
36. C. Galanos, M.A. Freudenberg, and W. Reutter Galactosamine-induced sensitization to the lethal effects of endotoxin Proc Natl Acad Sci USA 76 1979 5939 5943 (Pubitemid 10216692)
37. A. Mignon, N. Rouquet, M. Fabre, S. Martin, J.C. Pagès, and J.F. Dhainaut LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock Am J Respir Crit Care Med 159 1999 1308 1315 (Pubitemid 29202572)